CNS involvement in overactive bladder: pathophysiology and opportunities for pharmacological intervention.
about
The neural control of micturitionBotulinum Toxin A and Lower Urinary Tract Dysfunction: Pathophysiology and Mechanisms of ActionPreclinical evidence supporting the clinical development of central pattern generator-modulating therapies for chronic spinal cord-injured patients.Somatic modulation of spinal reflex bladder activity mediated by nociceptive bladder afferent nerve fibers in cats.Propranolol, but not naloxone, enhances spinal reflex bladder activity and reduces pudendal inhibition in cats.Prospective pharmacologic therapies for the overactive bladderSerotonin and noradrenaline reuptake inhibitors improve micturition control in miceRole of spinal metabotropic glutamate receptor 5 in pudendal inhibition of the nociceptive bladder reflex in cats.Animal models in urological disease and sexual dysfunction.Role of µ, κ, and δ opioid receptors in tibial inhibition of bladder overactivity in cats.The emergence of new drugs for overactive bladder.The overactive bladder: review of current pharmacotherapy in adults. Part 2: treatment options in cases refractory to anticholinergics.Beyond the lower urinary tract: the association of urologic and sexual symptoms with common illnesses.Pudendal but not tibial nerve stimulation inhibits bladder contractions induced by stimulation of pontine micturition center in catsSympathetic β-adrenergic mechanism in pudendal inhibition of nociceptive and non-nociceptive reflex bladder activity.Heart rate variability in overactive bladder experimental model.Role of spinal GABAA receptors in pudendal inhibition of nociceptive and nonnociceptive bladder reflexes in catsAlfuzosin for the treatment of storage symptoms suggestive of overactive bladder.Pathogenesis of enuresis: Towards a new understanding.Measures of autonomic nervous system activity and lower urinary tract symptoms.Characteristics of neurogenic voiding dysfunction in cerebellar stroke: a cross-sectional, retrospective video urodynamic study.Effects of PGE2 EP3/EP4 receptors on bladder dysfunction in mice with experimental autoimmune encephalomyelitis.Contribution of GABAA, Glycine, and Opioid Receptors to Sacral Neuromodulation of Bladder Overactivity in Cats.Sex difference in the contribution of GABAB receptors to tibial neuromodulation of bladder overactivity in cats.Overactive bladder in Parkinson's disease: alteration of brainstem raphe detected by transcranial sonography.Role of cannabinoid receptor type 1 in tibial and pudendal neuromodulation of bladder overactivity in cats.Involvement of interstitial cells of Cajal in bladder dysfunction in mice with experimental autoimmune encephalomyelitis.Effect of fesoterodine on urethral closure function in women with stress urinary incontinence assessed by urethral pressure reflectometry.
P2860
Q24619130-26F26FDA-1439-4F54-8A2C-1939300168D8Q26750535-C484AC19-4A1C-4554-8A97-E7EFB6817129Q33687734-533263F5-7690-451A-9CE9-C083DCAE02F1Q34201001-BD1D96AA-82E3-4198-B39B-03000E8131F8Q34800915-E6B6416E-51CC-49B0-ADEE-9AD149B473EEQ35076367-F4BAB6F1-76EC-4694-AF63-C8C27CFC0875Q35220015-04970435-B622-4881-A4C4-713FA251E72BQ35436958-B67B83C5-D2EF-40D5-8F42-C6114D6BD24FQ35545746-36382376-10DF-4C78-B23D-688F7987CD60Q36186158-FA65A0FF-92B1-4094-BA7E-F51463F1B734Q36407417-4E91F1BA-DFAC-4A2E-90B9-73262DE355E9Q36428476-B13E7A9C-CEEC-4984-9CB6-CD1672AC0907Q36676598-2E7BBE1A-E90F-4E19-80D7-5A45D72BCDB3Q36699845-35D28C90-C9A2-478E-AADB-1CB4920A241EQ37139478-9A09457E-D8FC-495D-A89A-83165D903BBAQ37321858-52A72451-C310-4927-BB36-F0812DAF8902Q37655976-068E2EF4-1085-480F-AD1B-073522EAFBF3Q38010781-62E50059-A36E-40D4-BA89-10BB925E1ED7Q39139107-1F7556ED-5F76-46C4-A434-6E6A826F307AQ41343896-635D09CB-4BC7-4FAD-A72F-44801502317FQ43696467-1C868915-B580-4307-ABB0-F81632BD857FQ43744872-E4143C08-7867-4C27-A3B8-BFCF90EAD26EQ44340665-8608A9D9-7A82-47A1-9890-58990B470201Q47917731-5E25A69B-A4DD-4380-A24D-E9A62A7BA00DQ48363957-E5DD38E3-9297-4126-BEE4-C1A95B04C2C2Q48403088-87D5B0AD-DCFE-4246-85F6-7346810198A9Q53346097-EBE16D8E-E1B7-4D96-8196-8B8DF156B44EQ54563949-81D2BAB9-777F-4215-8E8C-7F7DAA08B455
P2860
CNS involvement in overactive bladder: pathophysiology and opportunities for pharmacological intervention.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
CNS involvement in overactive ...... pharmacological intervention.
@ast
CNS involvement in overactive ...... pharmacological intervention.
@en
type
label
CNS involvement in overactive ...... pharmacological intervention.
@ast
CNS involvement in overactive ...... pharmacological intervention.
@en
prefLabel
CNS involvement in overactive ...... pharmacological intervention.
@ast
CNS involvement in overactive ...... pharmacological intervention.
@en
P1433
P1476
CNS involvement in overactive ...... pharmacological intervention.
@en
P2093
Karl-Erik Andersson
Rikard Pehrson
P304
P356
10.2165/00003495-200363230-00003
P577
2003-01-01T00:00:00Z
P6179
1049806197